Liver Fibrosis and 8-Year All-Cause Mortality Trajectories in the Aging Cohort of the Salus in Apulia Study
Age is a major contributor to the liver fibrosis rate and its adverse health-related outcomes, including mortality, but older populations are still under-explored. We investigated multimorbidity and inflammatory biomarkers in relation to the increasing liver fibrosis risk to delineate 8-year all-cau...
Guardado en:
Autores principales: | Roberta Zupo, Fabio Castellana, Sara De Nucci, Giovanni De Pergola, Madia Lozupone, Ilaria Bortone, Marco Castellana, Giancarlo Sborgia, Luisa Lampignano, Gianluigi Giannelli, Francesco Panza, Rodolfo Sardone |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/565a71e54596489084e2dcac39927d9b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Blancos terapéuticos potenciales para revertir la cirrosis hepática
por: García B,Leonel, et al.
Publicado: (2007) -
Trasplante hepático en Chile: Aspectos generales, indicaciones y contraindicaciones (Documento de consenso)
por: Hepp,Juan, et al.
Publicado: (2008) -
Obesidad: factor de riesgo para esteatohepatitis y fibrosis hepática
por: Poniachik T,Jaime, et al.
Publicado: (2002) -
Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study
por: Zhi-Qin Xie, et al.
Publicado: (2021) -
Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
por: Gwyneth Shook Ting Soon, et al.
Publicado: (2021)